| Year |
Citation |
Score |
| 2023 |
Lo T, Kushima I, Kimura H, Aleksic B, Okada T, Kato H, Inada T, Nawa Y, Torii Y, Yamamoto M, Kimura R, Funabiki Y, Kosaka H, Numata S, Kasai K, ... ... Yamasue H, et al. Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control study. Neuropsychopharmacology Reports. PMID 37915257 DOI: 10.1002/npr2.12370 |
0.307 |
|
| 2023 |
Okada N, Fukunaga M, Miura K, Nemoto K, Matsumoto J, Hashimoto N, Kiyota M, Morita K, Koshiyama D, Ohi K, Takahashi T, Koeda M, Yamamori H, Fujimoto M, Yasuda Y, ... ... Yamasue H, et al. Subcortical volumetric alterations in four major psychiatric disorders: a mega-analysis study of 5604 subjects and a volumetric data-driven approach for classification. Molecular Psychiatry. PMID 37537281 DOI: 10.1038/s41380-023-02141-9 |
0.338 |
|
| 2022 |
Kushima I, Nakatochi M, Aleksic B, Okada T, Kimura H, Kato H, Morikawa M, Inada T, Ishizuka K, Torii Y, Nakamura Y, Tanaka S, Imaeda M, Takahashi N, Yamamoto M, ... ... Yamasue H, et al. Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder. Biological Psychiatry. PMID 35667888 DOI: 10.1016/j.biopsych.2022.04.003 |
0.305 |
|
| 2021 |
Morimoto C, Nakamura Y, Kuwabara H, Abe O, Kasai K, Yamasue H, Koike S. Unique Morphometric Features of the Cerebellum and Cerebellocerebral Structural Correlation Between Autism Spectrum Disorder and Schizophrenia. Biological Psychiatry Global Open Science. 1: 219-228. PMID 36325298 DOI: 10.1016/j.bpsgos.2021.05.010 |
0.339 |
|
| 2020 |
Yassin W, Nakatani H, Zhu Y, Kojima M, Owada K, Kuwabara H, Gonoi W, Aoki Y, Takao H, Natsubori T, Iwashiro N, Kasai K, Kano Y, Abe O, Yamasue H, et al. Machine-learning classification using neuroimaging data in schizophrenia, autism, ultra-high risk and first-episode psychosis. Translational Psychiatry. 10: 278. PMID 32801298 DOI: 10.1038/S41398-020-00965-5 |
0.363 |
|
| 2020 |
Schmidt A, Davies C, Paloyelis Y, Meyer N, De Micheli A, Ramella-Cravaro V, Provenzani U, Aoki Y, Rutigliano G, Cappucciati M, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, ... ... Yamasue H, et al. Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis. Translational Psychiatry. 10: 203. PMID 32572020 DOI: 10.1038/S41398-020-00885-4 |
0.35 |
|
| 2020 |
Yokokura M, Takebasashi K, Takao A, Nakaizumi K, Yoshikawa E, Futatsubashi M, Suzuki K, Nakamura K, Yamasue H, Ouchi Y. In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study. Molecular Psychiatry. PMID 32439845 DOI: 10.1038/S41380-020-0784-7 |
0.325 |
|
| 2020 |
Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Usui K, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Azechi H, Watanabe Y, Hashimoto N, Narita H, Kusumi I, ... ... Yamasue H, et al. Differences in fractional anisotropy between the patients with schizophrenia and healthy comparison subjects. Molecular Psychiatry. 25: 697-698. PMID 32286531 DOI: 10.1038/S41380-020-0700-1 |
0.325 |
|
| 2020 |
Sasabayashi D, Takayanagi Y, Takahashi T, Mizukami Y, Katagiri N, Sakuma A, Obara C, Koike S, Nakamura M, Furuichi A, Kido M, Nishikawa Y, Noguchi K, Yamasue H, Matsumoto K, et al. T22. RELATIONSHIP BETWEEN CORTICAL THICKNESS AND FUNCTIONAL OUTCOME IN INDIVIDUALS AT RISK OF PSYCHOSIS Schizophrenia Bulletin. 46: S239-S240. DOI: 10.1093/Schbul/Sbaa029.582 |
0.325 |
|
| 2019 |
Ochi K, Ono N, Owada K, Kojima M, Kuroda M, Sagayama S, Yamasue H. Quantification of speech and synchrony in the conversation of adults with autism spectrum disorder. Plos One. 14: e0225377. PMID 31805131 DOI: 10.1371/Journal.Pone.0225377 |
0.385 |
|
| 2019 |
Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Usui K, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Azechi H, Watanabe Y, Hashimoto N, Narita H, Kusumi I, ... ... Yamasue H, et al. White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals. Molecular Psychiatry. PMID 31780770 DOI: 10.1038/S41380-019-0553-7 |
0.403 |
|
| 2019 |
Nemoto K, Shimokawa T, Fukunaga M, Yamashita F, Tamura M, Yamamori H, Yasuda Y, Azechi H, Kudo N, Watanabe Y, Kido M, Takahashi T, Koike S, Okada N, Hirano Y, ... ... Yamasue H, et al. Differentiation of schizophrenia using structural MRI with consideration of scanner differences: A real-world multi-site study. Psychiatry and Clinical Neurosciences. PMID 31587444 DOI: 10.1111/Pcn.12934 |
0.346 |
|
| 2019 |
Yamasue H. [Development of Novel Therapeutics for Core Symptoms of Autism Spectrum Disorder: An Integrative Approach of Clinical Trials, Neuroimaging, and Genomics]. Brain and Nerve = Shinkei Kenkyu No Shinpo. 71: 971-980. PMID 31506399 DOI: 10.11477/Mf.1416201389 |
0.389 |
|
| 2019 |
Yokokura M, Terada T, Bunai T, Nakaizumi K, Kato Y, Yoshikawa E, Futatsubashi M, Suzuki K, Yamasue H, Ouchi Y. Alterations in serotonin transporter and body image-related cognition in anorexia nervosa. Neuroimage. Clinical. 23: 101928. PMID 31491815 DOI: 10.1016/J.Nicl.2019.101928 |
0.316 |
|
| 2019 |
Yassin W, Kojima M, Owada K, Kuwabara H, Gonoi W, Aoki Y, Takao H, Natsubori T, Iwashiro N, Kasai K, Kano Y, Abe O, Yamasue H. Paternal age contribution to brain white matter aberrations in autism spectrum disorder. Psychiatry and Clinical Neurosciences. PMID 31271249 DOI: 10.1111/Pcn.12909 |
0.344 |
|
| 2019 |
Yamasue H, Aran A, Berry-Kravis E. Emerging pharmacological therapies in fragile X syndrome and autism. Current Opinion in Neurology. PMID 31045620 DOI: 10.1097/Wco.0000000000000703 |
0.313 |
|
| 2019 |
Iwashiro N, Takano Y, Natsubori T, Aoki Y, Yahata N, Gonoi W, Kunimatsu A, Abe O, Kasai K, Yamasue H. Aberrant attentive and inattentive brain activity to auditory negative words, and its relation to persecutory delusion in patients with schizophrenia. Neuropsychiatric Disease and Treatment. 15: 491-502. PMID 30858706 DOI: 10.2147/Ndt.S194353 |
0.353 |
|
| 2019 |
Higashida H, Munesue T, Kosaka H, Yamasue H, Yokoyama S, Kikuchi M. Social Interaction Improved by Oxytocin in the Subclass of Autism with Comorbid Intellectual Disabilities. Diseases (Basel, Switzerland). 7. PMID 30813294 DOI: 10.3390/Diseases7010024 |
0.375 |
|
| 2018 |
Benner S, Aoki Y, Watanabe T, Endo N, Abe O, Kuroda M, Kuwabara H, Kawakubo Y, Takao H, Kunimatsu A, Kasai K, Bito H, Kakeyama M, Yamasue H. Neurochemical evidence for differential effects of acute and repeated oxytocin administration. Molecular Psychiatry. PMID 30262887 DOI: 10.1038/S41380-018-0249-4 |
0.327 |
|
| 2018 |
Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, Morikawa M, Ishizuka K, Shiino T, Kimura H, Arioka Y, Yoshimi A, Takasaki Y, Yu Y, Nakamura Y, ... ... Yamasue H, et al. Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights. Cell Reports. 24: 2838-2856. PMID 30208311 DOI: 10.1016/J.Celrep.2018.08.022 |
0.407 |
|
| 2018 |
Owada K, Kojima M, Yassin W, Kuroda M, Kawakubo Y, Kuwabara H, Kano Y, Yamasue H. Computer-analyzed facial expression as a surrogate marker for autism spectrum social core symptoms. Plos One. 13: e0190442. PMID 29293598 DOI: 10.1371/Journal.Pone.0190442 |
0.372 |
|
| 2018 |
Wakuda T, Yokokura M, Nakaizumi K, Kato Y, Kameno Y, Futatsubashi M, Yoshikawa E, Magata Y, Ouchi Y, Yamasue H, Takei N. F148. A PILOT STUDY OF [11C] (R)-MEQAA PET BRAIN IMAGING ANALYSIS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTORS AVAILABILITY IN SCHIZOPHRENIA Schizophrenia Bulletin. 44: S277-S278. DOI: 10.1093/Schbul/Sby017.679 |
0.366 |
|
| 2017 |
Matsunaga M, Kawamichi H, Umemura T, Hori R, Shibata E, Kobayashi F, Suzuki K, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H, Ohira H. Neural and Genetic Correlates of the Social Sharing of Happiness. Frontiers in Neuroscience. 11: 718. PMID 29311795 DOI: 10.3389/Fnins.2017.00718 |
0.342 |
|
| 2017 |
Yamasue H, Domes G. Oxytocin and Autism Spectrum Disorders. Current Topics in Behavioral Neurosciences. PMID 28766270 DOI: 10.1007/7854_2017_24 |
0.398 |
|
| 2017 |
Sasabayashi D, Takayanagi Y, Takahashi T, Koike S, Yamasue H, Katagiri N, Sakuma A, Obara C, Nakamura M, Furuichi A, Kido M, Nishikawa Y, Noguchi K, Matsumoto K, Mizuno M, et al. Increased Occipital Gyrification and Development of Psychotic Disorders in Individuals With an At-Risk Mental State: A Multicenter Study. Biological Psychiatry. PMID 28709499 DOI: 10.1016/J.Biopsych.2017.05.018 |
0.389 |
|
| 2017 |
Matsunaga M, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H. Association between salivary serotonin and the social sharing of happiness. Plos One. 12: e0180391. PMID 28683075 DOI: 10.1371/Journal.Pone.0180391 |
0.307 |
|
| 2017 |
Yamasue H. [Voxel-Based Morphometry in Autism Spectrum Disorder]. Brain and Nerve = Shinkei Kenkyu No Shinpo. 69: 529-538. PMID 28479530 DOI: 10.11477/Mf.1416200779 |
0.411 |
|
| 2016 |
Takano Y, Aoki Y, Yahata N, Kawakubo Y, Inoue H, Iwashiro N, Natsubori T, Koike S, Gonoi W, Sasaki H, Takao H, Kasai K, Yamasue H. Neural basis for inferring false beliefs and social emotions in others among individuals with schizophrenia and those at ultra-high risk for psychosis. Psychiatry Research. 259: 34-41. PMID 27960147 DOI: 10.1016/J.Pscychresns.2016.11.003 |
0.306 |
|
| 2015 |
Watanabe T, Kuroda M, Kuwabara H, Aoki Y, Iwashiro N, Tatsunobu N, Takao H, Nippashi Y, Kawakubo Y, Kunimatsu A, Kasai K, Yamasue H. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain : a Journal of Neurology. PMID 26336909 DOI: 10.1093/Brain/Awv249 |
0.323 |
|
| 2015 |
Gong Q, Dazzan P, Scarpazza C, Kasai K, Hu X, Marques TR, Iwashiro N, Huang X, Murray RM, Koike S, David AS, Yamasue H, Lui S, Mechelli A. A Neuroanatomical Signature for Schizophrenia Across Different Ethnic Groups. Schizophrenia Bulletin. PMID 26264820 DOI: 10.1093/Schbul/Sbv109 |
0.323 |
|
| 2010 |
Yamasaki S, Yamasue H, Abe O, Suga M, Yamada H, Inoue H, Kuwabara H, Kawakubo Y, Yahata N, Aoki S, Kano Y, Kato N, Kasai K. Reduced gray matter volume of pars opercularis is associated with impaired social communication in high-functioning autism spectrum disorders. Biological Psychiatry. 68: 1141-7. PMID 20801427 DOI: 10.1016/J.Biopsych.2010.07.012 |
0.321 |
|
| 2009 |
Kirihara K, Araki T, Uetsuki M, Yamasue H, Hata A, Rogers MA, Iwanami A, Kasai K. Association Study between Auditory P3a/P3b Event-Related Potentials and Thought Disorder in Schizophrenia. Brain Imaging and Behavior. 3: 277-83. PMID 22005990 DOI: 10.1007/S11682-009-9069-0 |
0.313 |
|
| 2007 |
Maeda K, Kasai K, Uetsuki M, Hata A, Araki T, Rogers MA, Yamasue H, Iwanami A. Increased positive thought disorder with illness duration in patients with schizophrenia. Psychiatry and Clinical Neurosciences. 61: 687-90. PMID 18081634 DOI: 10.1111/J.1440-1819.2007.01730.X |
0.308 |
|
| 2007 |
Yamasue H, Suga M, Kasai K. [Investigating endophenotype of endogeneous psychotic disorders]. Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 27: 85-90. PMID 17633518 |
0.321 |
|
| 2005 |
Kirihara K, Araki T, Kasai K, Maeda K, Hata A, Uetsuki M, Yamasue H, Rogers MA, Kato N, Iwanami A. Confirmation of a relationship between reduced auditory P300 amplitude and thought disorder in schizophrenia. Schizophrenia Research. 80: 197-201. PMID 16169707 DOI: 10.1016/J.Schres.2005.08.003 |
0.313 |
|
| 2002 |
Kasai K, Iwanami A, Yamasue H, Kuroki N, Nakagome K, Fukuda M. Neuroanatomy and neurophysiology in schizophrenia. Neuroscience Research. 43: 93-110. PMID 12067745 DOI: 10.1016/S0168-0102(02)00023-8 |
0.345 |
|
| Show low-probability matches. |